[DMAC] YoY Quarter Result on 31-Dec-2020 [#Q4]

Stock
[DMAC] DiaMedica Therapeutics Inc.
Announcement Date
10-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- -31.54%
YoY- -69.35%
Quarter Report
DMAC's Result
DMAC's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 30,838 0 0 0 0 -4 0 -
PBT -5,139 -3,744 -3,239 -4,193 -2,478 -1,057 -1,010 31.13%
Tax 22 7 7 7 2 5 -26 -
NP -5,161 -3,751 -3,246 -4,200 -2,480 -1,062 -984 31.79%
Tax Rate - - - - - - - -
Total Cost 35,999 3,751 3,246 4,200 2,480 1,058 984 82.15%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -16.74 0.00 0.00 0.00 0.00 29,040.06 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.14 -0.14 -0.17 -0.25 -0.19 -0.09 -0.16 -2.19%
EPS Diluted -0.14 -0.14 -0.17 -0.25 -0.19 -0.09 -0.16 -2.19%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.